Lung Cancers Clinical Trials

20 recruiting

Lung Cancers Trials at a Glance

24 actively recruiting trials for lung cancers are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Shanghai, Bethesda, and Beijing. Lead sponsors running lung cancers studies include National Cancer Institute (NCI), Chris Goodman, and Central South University.

Browse lung cancers trials by phase

Treatments under study

About Lung Cancers Clinical Trials

Looking for clinical trials for Lung Cancers? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Cancers trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Cancers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 1

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Kidney CancersHead and Neck TumorsSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI)120 enrolled1 locationNCT06479811
Recruiting

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

Neuroendocrine CarcinomaSmall Cell Lung Cancers
Samsung Medical Center797 enrolled6 locationsNCT02688894
Recruiting

Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

Lung Cancers
Everest Detection, Inc.350 enrolled1 locationNCT06816121
Recruiting

Rapid Autopsy and Procurement of Cancer Tissue

Lung CancersMesotheliomaThymus Tumors+2 more
National Cancer Institute (NCI)275 enrolled1 locationNCT01851395
Recruiting
Phase 3

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Lung Cancers
George Washington University120 enrolled1 locationNCT06810375
Recruiting
Phase 1

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Advanced Solid TumorNon-small Cell Lung Cancers
M.D. Anderson Cancer Center52 enrolled1 locationNCT06130254
Recruiting

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Lung Cancer Associated With Cystic AirspacesMultiple Primary Lung Cancers
Central South University300 enrolled1 locationNCT06699979
Recruiting
Phase 1Phase 2

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

Breast CancerLung CancersOvarian Cancer+4 more
Filamon LTD80 enrolled3 locationsNCT06926075
Recruiting
Not Applicable

General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound

Lung CancersPeripheral Pulmonary Nodules
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval306 enrolled1 locationNCT06950515
Recruiting
Not Applicable

Precision Lung Cancer Survivorship Care Intervention

Lung CancersLung CancerCancer, Lung+12 more
Jerod L Stapleton, PhD300 enrolled1 locationNCT05857995
Recruiting
Phase 1Phase 2

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Lung CancersLocally AdvancedSolid Tumor Cancer+2 more
Avenzo Therapeutics, Inc.430 enrolled16 locationsNCT07038343
Recruiting

Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea

Lung CancersPulmonary NodulesLung Nodules+2 more
Ulsan University Hospital100 enrolled1 locationNCT07057648
Recruiting
Not Applicable

An Evaluation of Dose-escalation for Intrathoracic Tumours

Lung Cancers
Chris Goodman141 enrolled3 locationsNCT06794125
Recruiting
Not Applicable

A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery

Lung Cancers
Peking University Cancer Hospital & Institute174 enrolled2 locationsNCT06674252
Recruiting
Not Applicable

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

Lung CancersCancerColon Cancer+2 more
University of Calgary740 enrolled5 locationsNCT06960291
Recruiting
Phase 1

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Lung CancersSarcomaMelanoma
Guangzhou FineImmune Biotechnology Co., LTD.15 enrolled1 locationNCT06942143
Recruiting
Not Applicable

Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer

Lung Cancers
Guang'anmen Hospital of China Academy of Chinese Medical Sciences240 enrolled3 locationsNCT06926140
Recruiting
Not Applicable

Bright Light Therapy on Sleep Health in Lung Cancer Patients

Lung Cancers
Henry Ford Health System20 enrolled1 locationNCT07064395
Recruiting

Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI

Lung CancersCOPD
Shanghai Chest Hospital100 enrolled1 locationNCT07045532
Recruiting
Phase 2

Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer

Lung CancersRadiation Treatment for Tumors
Tianjin Medical University Cancer Institute and Hospital84 enrolled1 locationNCT06775678